Download PDF
CC BY-NC-ND 4.0 · Exp Clin Endocrinol Diabetes 2020; 128(05): 303-310
DOI: 10.1055/a-0833-8313
Article
Eigentümer und Copyright ©Georg Thieme Verlag KG 2019

Association Between Levels of Serum Insulin-like Growth Factor I and Functional Recovery, Mortality, and Recurrent Stroke at a 7-year Follow-up

N. David Åberg
1   Department of Internal Medicine, Institute of Medicine, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
4   Center of Brain Repair and Rehabilitation, The Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
,
Daniel Åberg
1   Department of Internal Medicine, Institute of Medicine, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
,
Cecilia Lagging
2   Department of Clinical Pathology and Genetics, Institute of Biomedicine, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
,
Lukas Holmegaard
3   Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
,
Petra Redfors
3   Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
,
Katarina Jood
3   Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
,
Michael Nilsson
4   Center of Brain Repair and Rehabilitation, The Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
5   Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia
,
Maria Åberg
6   Department of Primary Health Care, Institute of Medicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
,
Christian Blomstrand
3   Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
,
Johan Svensson
1   Department of Internal Medicine, Institute of Medicine, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
,
Christina Jern
2   Department of Clinical Pathology and Genetics, Institute of Biomedicine, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
3   Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
,
Jörgen Isgaard
1   Department of Internal Medicine, Institute of Medicine, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
› Author Affiliations
Further Information

Publication History

received 26 October 2018
revised 08 January 2019

accepted 14 January 2019

Publication Date:
01 July 2019 (online)

Also available at
   Permissions and Reprints

Abstract

Background The association of serum insulin-like growth factor I (s-IGF-I) with favorable outcome after ischemic stroke (IS) beyond 2 years is unknown. We investigated whether the levels of s-IGF-I 3 months post-stroke were associated with functional recovery up to 7 years after IS, considering also mortality and recurrent strokes.

Methods Patients (N=324; 65% males; mean age, 55 years) with s-IGF-I levels assessed 3 months after the index IS were included from the Sahlgrenska Academy Study on Ischemic Stroke (SAHLSIS). The modified Rankin Scale (mRS) was used to evaluate outcomes at 3 months, 2 and 7 years after IS, and recovery was defined as an improvement, no change, or deterioration in the shifts of mRS score. Baseline stroke severity was determined using the National Institutes of Health Stroke Scale (NIHSS).

Results The mRS score distributions were better in the above-median s-IGF-I group (>146.7 ng/ml). The s-IGF-I level was not associated with recurrent stroke (N=79) or death (N=44), although it correlated with recovery (r=0.12, P=0.035). In the regression analysis, s-IGF-I associated with recovery between 3 months and 7 years (but not between 2 and 7 years). The associations did not withstand adjustment for age and sex. For comparison, the corresponding associations between 3 months and 2 years withstood all adjustments.

Conclusion The association for s-IGF-I with long-term post-stroke recovery persists after 7 years, which is also reflected in the mRS score distributions at all time-points. The effects are however modest, and not driven by mortality or recurrent stroke.

Key words

cerebrovascular disease - insulin-like growth factor I - ischemic stroke - outcome - modified Rankin scale - NIHSS

Supplementary Material

 

  • References

  • 1 Åberg ND, Brywe KG, Isgaard J. Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain. Scientific World Journal 2006; 6: 53-80; doi:10.1100/tsw.2006.22
    CrossrefPubMedGoogle Scholar
  • 2 Parekh N, Roberts CB, Vadiveloo M. et al. Lifestyle, anthropometric, and obesity-related physiologic determinants of insulin-like growth factor-1 in the Third National Health and Nutrition Examination Survey (1988-1994). Ann Epidemiol 2010; 20: 182-193; doi:10.1016/j.annepidem.2009.11.008
    CrossrefPubMedGoogle Scholar
  • 3 Landin-Wilhelmsen K, Wilhelmsen L, Lappas G. et al. Serum insulin-like growth factor I in a random population sample of men and women: Relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clin Endocrinol (Oxf) 1994; 41: 351-357
    CrossrefPubMedGoogle Scholar
  • 4 Bondanelli M, Ambrosio MR, Onofri A. et al. Predictive value of circulating insulin-like growth factor I levels in ischemic stroke outcome. J Clin Endocrinol Metab 2006; 91: 3928-3934; doi:10.1210/jc.2006-1040
    CrossrefPubMedGoogle Scholar
  • 5 Denti L, Annoni V, Cattadori E. et al. Insulin-like growth factor 1 as a predictor of ischemic stroke outcome in the elderly. Am J Med 2004; 117: 312-317; doi:10.1016/j.amjmed.2004.02.049
    CrossrefPubMedGoogle Scholar
  • 6 Armbrust M, Worthmann H, Dengler R. et al. Circulating insulin-like growth factor-1 and insulin-like growth factor binding protein-3 predict three-months outcome after ischemic stroke. Exp Clin Endocrinol Diabetes 2017; 125: 485-491; doi:10.1055/s-0043-103965
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Ebinger M, Ipsen N, Leonards CO. et al. Circulating insulin-like growth factor binding protein-3 predicts one-year outcome after ischemic stroke. Exp Clin Endocrinol Diabetes 2015; 123: 461-465; doi:10.1055/s-0035-1554632
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Åberg D, Jood K, Blomstrand C. et al. Serum IGF-I levels correlate to improvement of functional outcome after ischemic stroke. J Clin Endocrinol Metab 2011; 96: E1055-E1064; doi:10.1210/jc.2010-2802
    CrossrefPubMedGoogle Scholar
  • 9 Johnsen SP, Hundborg HH, Sorensen HT. et al. Insulin-like growth factor (IGF) I, -II, and IGF binding protein-3 and risk of ischemic stroke. J Clin Endocrinol Metab 2005; 90: 5937-5941 doi:10.1210/jc.2004-2088
    CrossrefPubMedGoogle Scholar
  • 10 Jood K, Ladenvall C, Rosengren A. et al. Family history in ischemic stroke before 70 years of age: The Sahlgrenska Academy Study on Ischemic Stroke. Stroke 2005; 36: 1383-1387; doi:10.1161/01.STR.0000169944.46025.09
    CrossrefPubMedGoogle Scholar
  • 11 Redfors P, Hofgren C, Eriksson I. et al. The Barrow Neurological Institute screen for higher cerebral functions in cognitive screening after stroke. J Stroke Cerebrovasc Dis 2014; 23: 349-355; doi10.1016/j.jstrokecerebrovasdis.2013.04.026
    CrossrefPubMedGoogle Scholar
  • 12 Redfors P, Isaksen D, Lappas G. et al. Living alone predicts mortality in patients with ischemic stroke before 70 years of age: A long-term prospective follow-up study. BMC Neurol 2016; 16: 80; doi:10.1186/s12883-016-0599-y
    CrossrefPubMedGoogle Scholar
  • 13 Vandenbroucke JP, von Elm E, Altman DG. et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration. PLoS Med 2007; 4: e297; doi:10.1371/journal.pmed.0040297
    CrossrefPubMedGoogle Scholar
  • 14 Gray LJ, Ali M, Lyden PD. et al. Virtual International Stroke Trials Archive Collaboration. J Stroke Cerebrovasc Dis. 2009; 18: 466-468. doi:10.1016/j.jstrokecerebrovasdis.2009.02.003
    CrossrefPubMedGoogle Scholar
  • 15 Lai SM, Duncan PW. Stroke recovery profile and the Modified Rankin assessment. Neuroepidemiology 2001; 20: 26-30; doi:10.1159/000054754
    CrossrefPubMedGoogle Scholar
  • 16 Olsson S, Jood K, Blomstrand C. et al. Genetic variation on chromosome 9p21 shows association with the ischaemic stroke subtype large-vessel disease in a Swedish sample aged</=70. Eur J Neurol 2011; 18: 365-367; doi:10.1111/j.1468-1331.2010.03096.x
    CrossrefPubMedGoogle Scholar
  • 17 Burgers AM, Biermasz NR, Schoones JW. et al. Meta-analysis and dose-response metaregression: circulating insulin-like growth factor I (IGF-I) and mortality. J Clin Endocrinol Metab 2011; 96: 2912-2920; doi:10.1210/jc.2011-1377
    CrossrefPubMedGoogle Scholar
  • 18 Hallström B, Jonsson AC, Nerbrand C. et al. Lund Stroke Register: Hospitalization pattern and yield of different screening methods for first-ever stroke. Acta Neurol Scand 2007; 115: 49-54; doi:10.1111/j.1600-0404.2006.00738.x
    CrossrefPubMedGoogle Scholar
  • 19 Åberg ND, Åberg D, Jood K. et al. The change in circulating insulin-like growth factor I (IGF-I) after ischemic stroke is independently associated with outcome. In, European Stroke Organisation Conference. Gothenburg: European Stroke Journal; 2018: 342-343 (AS316-018)
    CrossrefGoogle Scholar
  • 20 Beilharz EJ, Russo VC, Butler G. et al. Co-ordinated and cellular specific induction of the components of the IGF/IGFBP axis in the rat brain following hypoxic-ischemic injury. Brain Res Mol Brain Res 1998; 59: 119-134
    CrossrefPubMedGoogle Scholar
  • 21 Mattlage AE, Rippee MA, Sandt J. et al. Decrease in insulin-like growth factor-1 and insulin-like growth factor-1 ratio in the first week of stroke is related to positive outcomes. J Stroke Cerebrovasc Dis 2016; 25: 1800-1806; doi:10.1016/j.jstrokecerebrovasdis.2016.03.054
    CrossrefPubMedGoogle Scholar
  • 22 Berrigan D, Potischman N, Dodd KW. et al. Race/ethnic variation in serum levels of IGF-I and IGFBP-3 in US adults. Growth Horm IGF Res 2009; 19: 146-155; doi:10.1016/j.ghir.2008.08.005
    CrossrefPubMedGoogle Scholar
  • 23 Papastathi C, Mavrommatis A, Mentzelopoulos S. et al. Insulin-like growth factor i and its binding protein 3 in sepsis. Growth Horm IGF Res 2013; 23: 98-104; doi:10.1016/j.ghir.2013.03.005
    CrossrefPubMedGoogle Scholar